|
October
20, 2000
Bloodborne
Pathogens
OSHA
29 CFR 1910.1030
Summary
of Key Provisions
Purpose
This regulation limits occupational
exposure to blood and other potentially infectious materials
since any exposure could result in transmission of bloodborne
pathogens which could lead to disease or death.
Scope
Covers all employees who could
be "reasonably anticipated" as the result of performing
their job duties to face contact with blood and other potentially
infectious materials. OSHA has not attempted to list all
occupations where exposures could occur. "Good Samaritan"
acts such as assisting a co-worker with a nosebleed would
not be considered occupational exposure.
Infectious materials include semen,
vaginal secretions, cerebrospinal fluid, synovial fluid, pleural
fluid, pericardial fluid, peritoneal fluid, amniotic fluid,
saliva in dental procedures, any body fluid visibly contaminated
with blood and all body fluids in situations where it is difficult
or impossible to differentiate between body fluids. They
also include any unfixed tissue or organ other than intact
skin from a human (living or dead) and human immunodeficiency
virus (HIV)- containing cell or tissue cultures, organ cultures
and HIV or hepatitis B (HBV)-containing culture medium or
other solutions as well as blood, organs or other tissues
from experimental animals infected with HIV or HBV.
Exposure Control Plan
Requires employers to identify,
in writing, tasks and procedures, as well as job classifications,
where occupational exposure to blood occurs--without regard
to personal protective clothing and equipment. It must also
set forth the schedule for implementing other provisions of
the standard and specify the procedure for evaluating circumstances
surrounding exposure incidents. The plan must be accessible
to employees and available to OSHA. Employers must review
and update it at least annually--more often if necessary to
accommodate workplace changes.
Methods of Compliance
Mandates universal precautions,
(treating body fluids/materials as if infectious) emphasizing
engineering and work practice controls. The standard stresses
hand-washing and requires employers to provide facilities
and ensure that employees use them following exposure to blood.
It sets forth procedures to minimize needlesticks, minimize
splashing and spraying of blood, ensure appropriate packaging
of specimens and regulated wastes and decontaminate equipment
or label it as contaminated before shipping to servicing facilities.
Employers must provide, at no cost,
and require employees to use appropriate personal protective
equipment such as gloves, gowns, masks, mouthpieces and resuscitation
bags and must clean, repair and replace these when necessary.
The standard requires a written
schedule for cleaning, identifying the method of decontamination
to be used in addition to cleaning following contact with
blood or other potentially infectious materials. lt specifies
methods for disposing of contaminated sharps and sets forth
standards for containers for these items and other regulated
waste. Further, the standard includes provisions for handling
contaminated laundry to minimize exposures.
HIV and HBV Research Laboratories
and Production Facilities
The Standard calls for these facilities
to follow standard microbiological practices and specifies
additional practices intended to minimize exposures of employees
working with concentrated viruses and reduce the risk of accidental
exposure for other employees at the facility. These facilities
must include required containment equipment and an autoclave
for decontamination of regulated waste and must be constructed
to limit risks and enable easy clean up. Additional training
and experience requirements apply to workers in these facilities.
Hepatitis B Vaccination
This Standard requires vaccinations
to be made available to all employees who have occupational
exposure to blood within 10 working days of assignment, at
no cost, at a reasonable time and place, under the supervision
of licensed physician/licensed healthcare professional and
according to the latest recommendations of the U.S. Public
Health Service (USPHS). Prescreening may not be required
as a condition of receiving the vaccine. Employees must sign
a declination form if they choose not to be vaccinated, but
may later opt to receive the vaccine at no cost to the employee.
Should booster doses later be recommended by the USPHS, employees
must be offered them.
Post-Exposure Evaluation and
Follow-Up
Specifies procedures to be made
available to all employees who have had an exposure incident
plus any laboratory tests must be conducted by an accredited
laboratory at no cost to the employee. Follow-up must include
a confidential medical evaluation documenting the circumstances
of exposure, identifying and testing the source individual
if feasible, testing the exposed employee's blood if he/she
consents, post-exposure prophylaxis, counseling and evaluation
of reported illnesses. Healthcare professionals must be provided
specified information to facilitate the evaluation and their
written opinion on the need for hepatitis B vaccination following
the exposure. Information such as the employee's ability to
receive the hepatitis B vaccine must be supplied to the employer.
All diagnoses must remain confidential.
Hazard Communication
Requires warning labels including
the orange or orange-red biohazard symbol affixed to containers
of regulated waste, refrigerators and freezers and other containers
which are used to store or transport blood or other potentially
infectious materials. Red bags or containers may be used
instead of labeling. When a facility uses universal precautions
in its handling of all specimens, labeling is not required
within the facility. Likewise, when all laundry is handled
with universal precautions, the laundry need not be labeled.
Blood which has been tested and found free of HIV or HBV and
released for clinical use, and regulated waste which has been
decontaminated, need not be labeled. Signs must be used to
identify restricted areas in HIV and HBV research laboratories
and production facilities.
Information and Training
This Standard mandates training
within 90 days of the effective date, initially upon assignment
and annually--employees who have received appropriate training
within the past year need only receive additional training
in items not previously covered. Training must include making
accessible a copy of the regulatory text of the standard and
explanation of its contents, general discussion on bloodborne
diseases and their transmission, exposure control plan, engineering
and work practice controls, personal protective equipment,
hepatitis B vaccine, response to emergencies involving blood,
how to handle exposure incidents, the post-exposure evaluation
and follow-up program, signs/labels/color-coding. There must
be opportunity for questions and answers, and the trainer
must be knowledgeable in the subject matter. Laboratory and
production facility workers must receive additional specialized
initial training.
Recordkeeping
Calls for medical records to be
kept for each employee with occupational exposure for the
duration of employment plus 30 years, must be confidential
and must include name and social security number; hepatitis
B vaccination status (including dates); results of any examinations,
medical testing and follow-up procedures; a copy of the healthcare
professional's written opinion; and a copy of information
provided to the healthcare professional. Training records
must be maintained for three years and must include dates,
contents of the training program or a summary, trainer's name
and qualifications, names and job titles of all persons attending
the sessions. Medical records must be made available to the
subject employee, anyone with written consent of the employee,
OSHA and NIOSH--they are not available to the employer. Disposal
of records must be in accord with OSHA's standard covering
access to records.
Dates
Effective date: March 6 1992.
Exposure control plan: May 5, 1992. Information and training
requirements and recordkeeping: June 4, 1992. And the following
other provisions take effect on July 6, 1992: engineering
and work practice controls, personal protective equipment,
housekeeping, special provisions covering HIV and HBV research
laboratories and production facilities, hepatitis B vaccination
and post-exposure evaluation and follow-up and labels and
signs.
Copyright © 2000 by WorkCare™
All Rights Reserved
See you next month, editor@osh.net
|